knowRX
Naviday Health is a digital health platform focused on empowering individuals to manage their health through life's personal transitions, starting with menopause. Their core product, The Owl App, provides an AI-guided menopause care plan, symptom tracking, and personalized health insights. The platform also offers PIXS, a web3 decentralized digital health platform utilizing blockchain and machine learning for secure health data exchange between patients, providers, and researchers. Naviday Health aims to bridge the gap between traditional healthcare and daily life by centralizing health data, improving medication adherence, and enabling informed decision-making through real-world evidence.
knowRX
Naviday Health is a digital health platform focused on empowering individuals to manage their health through life's personal transitions, starting with menopause. Their core product, The Owl App, provides an AI-guided menopause care plan, symptom tracking, and personalized health insights. The platform also offers PIXS, a web3 decentralized digital health platform utilizing blockchain and machine learning for secure health data exchange between patients, providers, and researchers. Naviday Health aims to bridge the gap between traditional healthcare and daily life by centralizing health data, improving medication adherence, and enabling informed decision-making through real-world evidence.
TL;DR
Headquarters: Austin, Texas, USA
Founded: 2019
Focus: Cloud-based digital health platform for medication management, patient engagement, and clinical trial awareness
Founders: David Franklin; James Powell, M.D.
Latest disclosed round: Pre-Seed (Oct 31, 2022)
Company Overview
Problem Domain
Medication adherence, patient engagement, and clinical-trial matching within digital health.
Founded
2019
Industry
Digital health / mHealth
Funding Track Record
Most recent round listed as Pre-Seed (Oct 31, 2022); public profiles indicate multiple early rounds (total rounds listed as 4).
Investor Signal
“Participated in accelerator and early-stage programs; public investor list includes EXPERT DOJO, Techstars, Village Capital, Johnson & Johnson, and MassChallenge.”